Two GH secretagogues in the same stack compete for the same receptor
2020 Sep 1;8(9):322
External resources Drugs.com interaction checker: tirzepatide and bupropion , the most widely used public drug interaction database for checking medication compatibility FDA prescribing information for tirzepatide (Mounjaro) , the complete official label including warnings, contraindications, and drug interaction data FDA prescribing information for bupropion (Wellbutrin) , the complete official label including seizure risk data and dosing guidelines SURMOUNT-1 trial results in the New England Journal of Medicine , the landmark clinical trial demonstrating tirzepatide weight loss efficacy in adults with obesity NIH review of GLP-1 agonist effects on gastric emptying and drug absorption , published research on how GLP-1 receptor agonists alter oral medication pharmacokinetics Taking wellbutrin and tirzepatide together is not the simple question people want it to be
1- Pattern and magnitude of GH/IGF-1: CJC-1295 prolongs GH/IGF-1 elevation (daysweeks) while preserving pulsatility
It is not approved for human consumption, veterinary use, cosmetic treatment, or therapeutic applications
For many individuals, the most significant weight loss is seen after 6 to 12 months of consistent use